Literature DB >> 11919333

Differential diagnosis between Pendred and pseudo-Pendred syndromes: clinical, radiologic, and molecular studies.

Laura Fugazzola1, Nadia Cerutti, Deborah Mannavola, Antonino Crino, Alessandra Cassio, Pietro Gasparoni, Guia Vannucchi, Paolo Beck-Peccoz.   

Abstract

The disease gene for Pendred syndrome has been recently characterized and named PDS. It codes for a transmembrane protein called pendrin, which is highly expressed at the apical surface of the thyroid cell and functions as a transporter of chloride and iodide. Pendrin is also expressed at the inner ear level, where it appears to be involved in the maintenance of the endolymph homeostasis in the membranous labyrinth, and in the kidney, where it mediates chloride-formate exchange and bicarbonate secretion. Mutations in the PDS gene and the consequent impaired function of pendrin leads to the classic phenotype of Pendred syndrome, i.e. dyshormonogenic goiter and congenital sensorineural hearing loss. In the present study, we performed a detailed clinical, radiologic, and molecular analysis of six families presenting with clinical diagnosis of Pendred syndrome. In two families a homozygous pattern for PDS mutations was found, whereas the affected members of the other four families were compound heterozygotes. One family did not harbor PDS mutations. Among the four novel mutations described, one is a transversion in exon 2 (84C>A), leading to the substitution S28R. Two other novel mutations lie in exon 4 (398T>A) and in exon 16 (1790T>C), leading to the substitutions S133T and L597S, respectively. The fourth novel mutation (1614+1G>A) is located in the first base pair of intron 14, probably affecting the splicing of the PDS gene. Clinically, all patients had goiter with positive perchlorate test, hypothyroidism, and severe or profound sensorineural hearing loss. In all the individuals harboring PDS mutations, but not in the family without PDS mutations, inner ear malformations, such as enlargement of the vestibular aqueduct and of the endolymphatic duct and sac, were documented. The pseudo-Pendred phenotype exhibited by the family without PDS mutations is likely caused by an autoimmune thyroid disease associated with a sensorineural hearing loss of different origin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11919333     DOI: 10.1203/00006450-200204000-00013

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  21 in total

1.  Extremely discrepant mutation spectrum of SLC26A4 between Chinese patients with isolated Mondini deformity and enlarged vestibular aqueduct.

Authors:  Shasha Huang; Dongyi Han; Yongyi Yuan; Guojian Wang; Dongyang Kang; Xin Zhang; Xiaofei Yan; Xiaoxiao Meng; Min Dong; Pu Dai
Journal:  J Transl Med       Date:  2011-09-30       Impact factor: 5.531

2.  Anion translocation through an Slc26 transporter mediates lumen expansion during tubulogenesis.

Authors:  Wei Deng; Florian Nies; Anja Feuer; Ivana Bocina; Dominik Oliver; Di Jiang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-26       Impact factor: 11.205

3.  Reduction of Cellular Expression Levels Is a Common Feature of Functionally Affected Pendrin (SLC26A4) Protein Variants.

Authors:  Vanessa C S de Moraes; Emanuele Bernardinelli; Nathalia Zocal; Jhonathan A Fernandez; Charity Nofziger; Arthur M Castilho; Edi L Sartorato; Markus Paulmichl; Silvia Dossena
Journal:  Mol Med       Date:  2016-01-04       Impact factor: 6.354

4.  Functional characterization of pendrin mutations found in the Israeli and Palestinian populations.

Authors:  Silvia Dossena; Charity Nofziger; Zippora Brownstein; Moien Kanaan; Karen B Avraham; Markus Paulmichl
Journal:  Cell Physiol Biochem       Date:  2011-11-18

5.  Identification of allelic variants of pendrin (SLC26A4) with loss and gain of function.

Authors:  Silvia Dossena; Aigerim Bizhanova; Charity Nofziger; Emanuele Bernardinelli; Josef Ramsauer; Peter Kopp; Markus Paulmichl
Journal:  Cell Physiol Biochem       Date:  2011-11-18

6.  Absence of primary hypothyroidism and goiter in Slc26a4 (-/-) mice fed on a low iodine diet.

Authors:  D Calebiro; P Porazzi; M Bonomi; S Lisi; A Grindati; D De Nittis; L Fugazzola; M Marinò; G Bottà; L Persani
Journal:  J Endocrinol Invest       Date:  2010-09-09       Impact factor: 4.256

7.  Mutations in the SLC26A4 (pendrin) gene in patients with sensorineural deafness and enlarged vestibular aqueduct.

Authors:  F Bogazzi; D Russo; F Raggi; F Ultimieri; S Berrettini; F Forli; L Grasso; C Ceccarelli; S Mariotti; A Pinchera; L Bartalena; E Martino
Journal:  J Endocrinol Invest       Date:  2004-05       Impact factor: 4.256

8.  Spectrum of DNA variants for non-syndromic deafness in a large cohort from multiple continents.

Authors:  Denise Yan; Demet Tekin; Guney Bademci; Joseph Foster; F Basak Cengiz; Abhiraami Kannan-Sundhari; Shengru Guo; Rahul Mittal; Bing Zou; Mhamed Grati; Rosemary I Kabahuma; Mohan Kameswaran; Taye J Lasisi; Waheed A Adedeji; Akeem O Lasisi; Ibis Menendez; Marianna Herrera; Claudia Carranza; Reza Maroofian; Andrew H Crosby; Mariem Bensaid; Saber Masmoudi; Mahdiyeh Behnam; Majid Mojarrad; Yong Feng; Duygu Duman; Alex M Mawla; Alex S Nord; Susan H Blanton; Xue Z Liu; Mustafa Tekin
Journal:  Hum Genet       Date:  2016-06-25       Impact factor: 4.132

9.  Hypo-functional SLC26A4 variants associated with nonsyndromic hearing loss and enlargement of the vestibular aqueduct: genotype-phenotype correlation or coincidental polymorphisms?

Authors:  Byung Yoon Choi; Andrew K Stewart; Anne C Madeo; Shannon P Pryor; Suzanne Lenhard; Rick Kittles; David Eisenman; H Jeffrey Kim; John Niparko; James Thomsen; Kathleen S Arnos; Walter E Nance; Kelly A King; Christopher K Zalewski; Carmen C Brewer; Thomas Shawker; James C Reynolds; John A Butman; Lawrence P Karniski; Seth L Alper; Andrew J Griffith
Journal:  Hum Mutat       Date:  2009-04       Impact factor: 4.878

10.  Solitary thyroid nodule as presenting symptom of Pendred syndrome caused by a novel splice-site mutation in intron 8 of the SLC26A4 gene.

Authors:  Guy Massa; Nele Jaenen; Sebastien Janssens de Varebeke; Nils Peeters; Wim Wuyts
Journal:  Eur J Pediatr       Date:  2003-08-15       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.